Abstract
Baseline population opinions on human papillomavirus (HPV) and HPV vaccination must be understood before physicians can address knowledge gaps in that population and encourage timely vaccination. To determine the opinions of parents of children age 9 to 18 on HPV-related oropharyngeal cancers (OPC); the associations with education level, socioeconomic status, and having a family member/friend with OPC; and the main concerns against having a vaccination., An anonymous survey was created and administered. Parents were asked to complete the survey if they met the inclusion criteria. After the survey, results were tabulated, and the answers for each question were analyzed. The target population was surveyed in the clinic. The target population was parents with children between 9 and 18 years old: the background knowledge and awareness of HPV-related OPC and associations with education level, socioeconomic status, having a family member/friend with OPC, and concerns about vaccination. Our study results showed that the age of parents, education level, marital status, personal vaccination status, and gender of the child are significant factors for background knowledge about HPV-related diseases. Similarly, the education level, the gender of the child, and personal vaccination status are significant factors towards attitudes against having children vaccinated. There is a strong correlation between background knowledge and attitudes. The main issues about vaccination are concerns about effectiveness and side effects, concerns about safe sex experiences, and the cost of vaccination. This is the first study designed to provide information on parents’ knowledge of HPV-related cancers, prevalence of HPV vaccination, and attitudes and concerns about HPV vaccination in the USA. The lack of awareness of HPV-related cancers is a significant factor in attitudes against HPV vaccination.
Similar content being viewed by others
References
Saraiya M, Unger ER, Thompson TD et al (2015) US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. J Natl Cancer Inst. 107(6):djv086. https://doi.org/10.1093/jnci/djv086
Jemal A, Simard EP, Dorell C, Noone AM, Markowitz LE, Kohler B, Eheman C, Saraiya M, Bandi P, Saslow D, Cronin KA, Watson M, Schiffman M, Henley SJ, Schymura MJ, Anderson RN, Yankey D, Edwards BK (Feb 2013) Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst 105(3):175–201. https://doi.org/10.1093/jnci/djs491
Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, Jordan RC, Altekruse S, Anderson WF, Rosenberg PS, Gillison ML (Nov 2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29(32):4294–4301. https://doi.org/10.1200/JCO.2011.36.4596
Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C (Oct 2015) Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol 33(29):3235–3242. https://doi.org/10.1200/JCO.2015.61.6995
Dodd RH, Waller J, Marlow LA (2016) Human papillomavirus and head and neck cancer: psychosocial impact in patients and knowledge of the link - a systematic review. Clin Oncol (R Coll Radiol) 28(7):421–439. https://doi.org/10.1016/j.clon.2016.02.012
Khan N, Tomar SL (Jan 2020) The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015. J Am Dent Assoc 151(1):51–58. https://doi.org/10.1016/j.adaj.2019.08.022
Prue G, Lawler M, Baker P, Warnakulasuriya S (Sep 2017) Human papillomavirus (HPV): making the case for ‘immunisation for all’. Oral Dis 23(6):726–730. https://doi.org/10.1111/odi.12562
Shah MD, Glenn BA, Chang LC et al (2020) Reducing missed opportunities for human papillomavirus vaccination in school-based health centers: impact of an intervention. Acad Pediatr. 20(8):1124–1132. https://doi.org/10.1016/j.acap.2020.04.002
Berman TA, Schiller JT (Jun 2017) Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer. 123(12):2219–2229. https://doi.org/10.1002/cncr.30588
Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, Wilson C (Oct 2008) Men’s attitudes toward receiving the human papillomavirus vaccine. J Low Genit Tract Dis 12(4):276–281. https://doi.org/10.1097/LGT.0b013e318167913e
Lenselink CH, Schmeink CE, Melchers WJ et al (2008) Young adults and acceptance of the human papillomavirus vaccine. Public Health 122(12):1295–1301. https://doi.org/10.1016/j.puhe.2008.02.010
Jones M, Cook R (2008) Intent to receive an HPV vaccine among university men and women and implications for vaccine administration. J Am Coll Health 57(1):23–32. https://doi.org/10.3200/JACH.57.1.23-32
Reiter PL, Brewer NT, Smith JS (Jun 2010) Human papillomavirus knowledge and vaccine acceptability among a national sample of heterosexual men. Sex Transm Infect 86(3):241–246. https://doi.org/10.1136/sti.2009.039065
Benavidez G, Asare M, Lanning B, Ylitalo K, Fakhoury C, Thompson N, Boozer K, Mamudu HM (May 2020) Young adults’ human papillomavirus-related knowledge: source of medical information matters. Public Health 182:125–130. https://doi.org/10.1016/j.puhe.2020.01.020
Rohrbach MR, Wieland AM (2017) A survey of Wisconsin pediatricians’ knowledge and practices regarding the human papillomavirus vaccine. Otolaryngol Head Neck Surg 156(4):636–641. https://doi.org/10.1177/0194599817695806
Berger MH, Haidar YM, Bitner B, Trent M, Tjoa T (2019) Practice patterns and knowledge among California pediatricians regarding human papillomavirus and its relation to head and neck cancer. Am J Otolaryngol 40(4):525–529. https://doi.org/10.1016/j.amjoto.2019.04.011
Laitman BM, Ronner L, Oliver K, Genden E (2020) US medical trainees’ knowledge of human papilloma virus and head and neck cancer. Otolaryngol Head Neck Surg 162(1):56–59. https://doi.org/10.1177/0194599819886117
Prevention CfDCa (2020) Recommended vaccinations for children (7-18 years old) parent-friendly version. Accessed 11/10/2020. https://www.cdc.gov/vaccines/schedules/easy-to-read/adolescent-easyread.html
Shiels MS, Kreimer AR, Coghill AE, Darragh TM, Devesa SS (Oct 2015) Anal cancer incidence in the United States, 1977-2011: distinct patterns by histology and behavior. Cancer Epidemiol Biomark Prev 24(10):1548–1556. https://doi.org/10.1158/1055-9965.EPI-15-0044
Della Polla G, Pelullo CP, Napolitano F, Angelillo IF (Apr 2020) HPV vaccine hesitancy among parents in Italy: a cross-sectional study. Hum Vaccin Immunother:1–8. https://doi.org/10.1080/21645515.2020.1744367
Dayyani F, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS (2010) Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2:15. https://doi.org/10.1186/1758-3284-2-15
Lowy DR, Solomon D, Hildesheim A, Schiller JT, Schiffman M (Oct 2008) Human papillomavirus infection and the primary and secondary prevention of cervical cancer. Cancer. 113(7 Suppl):1980–1993. https://doi.org/10.1002/cncr.23704
Lee LY, Garland SM (2017) Human papillomavirus vaccination: the population impact. F1000Res 6:866. https://doi.org/10.12688/f1000research.10691.1
Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jimenez S, Schiller JT, Lowy DR, van Doorn LJ, Wacholder S, Kreimer AR, for the CVT Vaccine Group (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 8(7):e68329. https://doi.org/10.1371/journal.pone.0068329
Harder T, Wichmann O, Klug SJ, van der Sande MAB, Wiese-Posselt M (Jul 2018) Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review. BMC Med 16(1):110. https://doi.org/10.1186/s12916-018-1098-3
Villa A, Patton LL, Giuliano AR et al (2020) Summary of the evidence on the safety, efficacy, and effectiveness of human papillomavirus vaccines: umbrella review of systematic reviews. J Am Dent Assoc 151(4):245–254.e24. https://doi.org/10.1016/j.adaj.2019.10.010
Han JJ, Beltran TH, Song JW, Klaric J, Choi YS (Jun 2017) Prevalence of genital human papillomavirus infection and human papillomavirus vaccination rates among US adult men: National Health and Nutrition Examination Survey (NHANES) 2013-2014. JAMA Oncol 3(6):810–816. https://doi.org/10.1001/jamaoncol.2016.6192
Daley MF, Liddon N, Crane LA, Beaty BL, Barrow J, Babbel C, Markowitz LE, Dunne EF, Stokley S, Dickinson LM, Berman S, Kempe A (Dec 2006) A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics. 118(6):2280–2289. https://doi.org/10.1542/peds.2006-1946
Khurana S, Sipsma HL, Caskey RN (Mar 2015) HPV vaccine acceptance among adolescent males and their parents in two suburban pediatric practices. Vaccine. 33(13):1620–1624. https://doi.org/10.1016/j.vaccine.2015.01.038
Ferris DG, Samakoses R, Block SL et al (2017) 4-Valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents after 10 years. Pediatrics. 140(6). https://doi.org/10.1542/peds.2016-3947
Wong LP, Edib Z, Alias H, Mohamad Shakir SM, Raja Muhammad Yusoff RNA, Sam IC, Zimet GD (Oct 2017) A study of physicians’ experiences with recommending HPV vaccines to adolescent boys. J Obstet Gynaecol 37(7):937–943. https://doi.org/10.1080/01443615.2017.1317239
Dilley SE, Peral S, Straughn JM, Scarinci IC (2018) The challenge of HPV vaccination uptake and opportunities for solutions: lessons learned from Alabama. Prev Med. 113:124–131. https://doi.org/10.1016/j.ypmed.2018.05.021
Reiter PL, McRee AL, Pepper JK, Brewer NT (2012) Default policies and parents’ consent for school-located HPV vaccination. J Behav Med 35(6):651–657. https://doi.org/10.1007/s10865-012-9397-1
Lack A, Hiligsmann M, Bloem P, Tünneßen M, Hutubessy R (Oct 2020) Parent, provider and vaccinee preferences for HPV vaccination: a systematic review of discrete choice experiments. Vaccine. 38(46):7226–7238. https://doi.org/10.1016/j.vaccine.2020.08.078
Prevention CfDCa (2020) Vaccines for Children Program (VFC). Accessed 11/10/2020, https://www.cdc.gov/vaccines/programs/vfc/index.html
Gilkey MB, Grabert BK, Malo TL, Hall ME, Brewer NT (2020) Physicians’ rhetorical strategies for motivating HPV vaccination. Soc Sci Med 266:113441. https://doi.org/10.1016/j.socscimed.2020.113441
Vielot NA, Islam JY, Sanusi B et al (2020) Overcoming barriers to adolescent vaccination: perspectives from vaccine providers in North Carolina. Women Health 60(10):1129–1140. https://doi.org/10.1080/03630242.2020.1802639
Evans L, Matley E, Oberbillig M, Margetts E, Darrow L (Aug 2020) HPV knowledge and attitudes among medical and professional students at a Nevada University: a focus on oropharyngeal cancer and mandating the vaccine. J Cancer Educ 35(4):774–781. https://doi.org/10.1007/s13187-019-01529-y
Acknowledgments
All authors thank Dr. Hasan Almekdash, Ms. Cathy Lovett, and the Clinical Research Institute for their help during the IRB application process.
Funding
This study was funded by the American Head and Neck Society: Community Service Award (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dundar, Y., Eldem, I., Schwartz, C. et al. Screening Awareness of HPV-Related Oropharyngeal Cancers and Attitudes and Concerns towards HPV Vaccination Among Parents. J Canc Educ 37, 1152–1160 (2022). https://doi.org/10.1007/s13187-020-01932-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13187-020-01932-w